Equities

Haw Par Corporation Ltd

Haw Par Corporation Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SGD)11.17
  • Today's Change-0.01 / -0.09%
  • Shares traded24.10k
  • 1 Year change+13.17%
  • Beta0.6388
Data delayed at least 10 minutes, as of Nov 22 2024 09:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of SGD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income229159116
Depreciation/depletion6.055.686.46
Non-Cash items(163)(113)(90)
Cash taxes paid, supplemental8.987.127.98
Cash interest paid, supplemental1.640.340.03
Changes in working capital(9.99)(11)(14)
Total cash from operations634119
INVESTING
Capital expenditures(7.77)(20)(4.38)
Other investing and cash flow items, total266(242)92
Total cash from investing258(262)88
FINANCING
Financing cash flow items(1.64)(0.64)(0.03)
Total cash dividends paid(77)(66)(66)
Issuance (retirement) of stock, net00.211.47
Issuance (retirement) of debt, net(0.18)29(0.18)
Total cash from financing(79)(38)(65)
NET CHANGE IN CASH
Foreign exchange effects(1.61)(3.54)0.58
Net change in cash240(262)42
Net cash-begin balance/reserved for future use334596554
Net cash-end balance/reserved for future use574334596
SUPPLEMENTAL INCOME
Depreciation, supplemental6.055.686.46
Cash interest paid, supplemental1.640.340.03
Cash taxes paid, supplemental8.987.127.98
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.